Hemoglobin Solutions as Blood Substitutes

REFERENCES

• Amberson WR. Blood substitutes. Biol Rev. 1937;12-48.
   Google Scholar
• Bonhard K. Acute oxygen supply by infusion of hemoglobi n solutions. Fed Proc. 1975;34:1466.
   PubMedGoogle Scholar
• Browdie Amberson D, Smith H. Stroma-free hemoglo-bin. Simplifed preparation and in vivo and in vitro effects on coagulation in rabbits. Am J Surg. 1975; 129:365.
   Google Scholar
• Collins J, Braitberg A, Butcher A Jr. Changes in lung and body weight and lung water content in rats treated for hemorrhage with various fuids. Surgery. 1973;73(3):401–411.
   Google Scholar
• Kaplan HR, Murphy VS. Hemoglobi n solution: A poten- tial oxygen transporting plasma volume expander. Fed Proc. 1975;34:1461.
   PubMedGoogle Scholar
• Mok W, Chen D, Mazur A. Cross-linked hemoglobins as potential plasma protein expanders. Fed Proc. 1975;34:1458.
   PubMedGoogle Scholar
• Moss GS, Der Woskin R, Cochin A. Stroma-free hemoglobin. Preparation and observations on in vitro changes in coagulation. Surgery. 1973;74:198.
   PubMedGoogle Scholar
• Moss GS, Der Woskin R, Rosen AL. Transport of oxy- gen and carbon dioxide by hemoglobin-saline solu-tion in the red cell-free primate. Surg Gynecol Obstet. 1976;142:357.
   PubMedGoogle Scholar
• Ozkan A, Wilson RH, Newfeld AH. Plasma expanders-A review. Med Serv J Can. 1966;22:781.
   Google Scholar
• Peskin GW, O’Brien K, Rabiner SF. Stroma-free hemo-globin solution: The “ideal” blood substitute? Surgery. 1969;66:185.
   Google Scholar
• Rabiner SF. Hemoglobin solution as a plasma expander. Fed Proc. 1975;34:1454.
   PubMedGoogle Scholar
• Rabiner SF, Helbert JR, Lopas H, et al. Evaluation of stroma-free hemoglobi n solution for use as aplasma ex-pander. J Exp Med. 1967;126:1127.
   PubMed Web of Science ®Google Scholar
• Rabiner SF, O’Briedn K, Peskin GW, et al. Further stud- ies with stroma-free hemoglobin solution. Ann Surg. 1970;171:615.
   PubMed Web of Science ®Google Scholar
• Thompson WL. Plasma substitutes. J. S. Carolina Med. Assoc. 1960;56:456.
   Google Scholar
• Beisang AA, Feemster J, Dietzman RH, et al. Damage assay of kidneys frozen by intraarterial perfusion with a fuorocarbon. Fed Proc. 1970;29:1782.
   Google Scholar
• Geyer RP. Substitutes for blood and its components. Prog Clin Biol Res. 1978;19:1.
   Google Scholar
• Geyer RP. Fluorocarbon-polyol artifcail blood substiutes. N Engl J Med. 1973;289:1077.
   PubMed Web of Science ®Google Scholar
• Clark LC Jr. Perfuorodecalin as a red cell substitute. Prog Clin Biol Res. 1978;119:69.
   Google Scholar
• Sargent JW, Seff RJ. Properties of perfuorinated liquids. Fed Proc. 1970;29:1699.
   PubMedGoogle Scholar
• Sloviter HA, Yamada H, Ogoshi S. Some effects of ad-ministered dispersed fuorocarbons in animals. Fed Proc. 1970;29:1755.
   PubMedGoogle Scholar
• Clark MC, Weiman DS, Pate JW, Gir S. Perfuorocarbons: Future clinical possibilities. J Invest Surg. 1997;10:357–365.
   PubMed Web of Science ®Google Scholar
• Birndorf NI, Lopas H. Effect of red cell stroma-free hemoglobi n solution on renal function in monkeys. J Appl Physiol. 1970;29:573.
   PubMed Web of Science ®Google Scholar
• DeVenuto F, Moores WY, Zegna AI, et al. Total and partial blood exchange in the rat with hemoglobin prepared by crystallization. Transfusion. 1977;17:555.
   PubMedGoogle Scholar
• Amberson WR, Flexner J, Steggerada FR, et al. On use of Ringer-Locke solutions containing hemoglobin as a substitute for normal blood in mammals. J Cell Comp Physiol. 1934;5:359.
   Google Scholar
• DeVenuto F, Zegna AI. Plasma oncotic pressure of the rat during and after blood exchange with crys-talline hemoglobi n solution. Surg Gynecol Obstet. 1978;147:379.
   Google Scholar
• Usami S, Chien S, Gregersen MI. Hemoglobin solution as a plasma expander: effects on blood viscosity. Proc Soc Exp Biol Med. 1971;136:1232.
   PubMedGoogle Scholar
• DeVenuto F. Stability of crystalline hemaglobin solution during extended storage. J Lab Clin Med. 1978;92:946.
   PubMedGoogle Scholar
• Hamilton PB, Farr LE, Hiller A, et al. Preparation of hemoglobi n solutions for intravenous infusion. J Exp Med. 1947;86:455.
   PubMed Web of Science ®Google Scholar
• Cochin A, Das Gupta TK, Der Woskin R, et al. Immuno-genic properties of stroma vs stroma-free hemoglobin solutions. Surg Forum. 1972;23:19.
   PubMedGoogle Scholar
• Sasazuki T. Studies on haptoglobin. I. Immunochemical properties of haptoglobi n and antihemoglobin antibody. Proc Jpn Acad. 1970;46:820.
   Google Scholar
• Sellards AW, Minot GR. Injection of hemoglobi n in man and its relation to blood destruction, with special refer-ence to the anemias. J Med Res. 1916;34:469.
   PubMedGoogle Scholar
• Feola M, Gonzalez H, Canizaro PC, et al. Development of a bovine stroma-free hemoglobi n solution as a blood substitute. Surg Gynecol Obstet. 1983;157:399–408.
   PubMedGoogle Scholar
• Hamilton PB, Hiller A, Van Slyke DD. Renal effects of hemoglobi n infusionsin dogs in hemorrhagic shock. J Exp Med. 1947;86:477.
   PubMedGoogle Scholar
• Baker SB, Dawes RLF. Experimental hemoglobinuri c nephrosis. J Pathol Bacteriol. 1964;87:49.
   PubMedGoogle Scholar
• Baker SL, Dodds EC. Obstruction of renal tubules during excretion of hemoglobin. Br J Exp Pathol. 1925;6:247.
   Google Scholar
• Brandt JL, Frank NR, Lichtman HC. The effect of hemoglobi n solutions on renal functions in man. Blood. 1951;6:1152.
   PubMed Web of Science ®Google Scholar
• Jaenicke JR. The renal lesion associated with hemo-globinemia. I. Its production and functional evaluation in the rat. J Exp Med. 1966;123:523.
   Google Scholar
• Jaenicke JR, Schneeberger EE. The renal lesion associated with hemoglobinemia. II. Its structural characteristics in the rat. J Exp Med. 1966;123:537.
   Google Scholar
• Rabiner SF, Friedman L. The role of intravascular hemoly-sis and the reticuloendothelial system in the production of a hypercoaguable state. Br J Hematol. 1968;14:105.
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Holland PV. Pathogenesis of the acute renal failure associated with incompatible transfusion. Lancet. 1967;2:1169.
   Google Scholar
• Palani CK, DeVoskin R, Moss GS. Scope and limitations of stroma-free hemoglobin solution as an oxygen-carrying blood substitute. Surg Clin North Am. 1975;55:3.
   PubMedGoogle Scholar
• Savitsky JP, Doczi J, Black J, et al. A clinical saftey trial of stroma-free hemoglobin. Clin Pharmacol Ther. 1978;23:73–80.
   PubMed Web of Science ®Google Scholar
• DeVenuto F, Zuck TF, Zegna AI, et al. Characterization of stroma-free hemoglobin prepared by crystallization. J Lab Clin Med. 1977;89:509.
   PubMed Web of Science ®Google Scholar
• Drabkin DI. A simplifed technique for large scale crystal- lization of human oxyhemoglobin. Isomorphous trans-formations of hemoglobin and myoglobin in the crys-talline state. Arch Biochem. 1949;21:224.
   PubMedGoogle Scholar
• Drabkin DL. Spectophotomeri c studies. XIV. The crystal- lographic and optical properties of the hemoglobin of man in comparison with those of other species. J Biol Chem. 1946;164:703.
   PubMed Web of Science ®Google Scholar
• DeVenuto F, Busse KR, Zegna AI. Oxygen transport after hemodilution of human blood with crystalline hemoglobi n solution. Surg Gynecol Obstet. 1981;153:332–336.
   PubMedGoogle Scholar
• Greenburg AG, Elia C, Levine B, et al. Hemoglobi n solution and the oxyhemoglobin dissociation curve. J Trauma. 1975;15:943.
   PubMedGoogle Scholar
• Dawson RB, Ellis TJ. Hemoglobin function of blood stored at 4 C in ACD and CPD with adenine and iosine. Transfusion 1970;10:113.
   Google Scholar
• Benesch RE, Benesch R, Renthal RD, et al. Affnity label-ing of the polyphosphat e binding site of hemoglobin. Biochemistry. 1972;11:3576.
   PubMed Web of Science ®Google Scholar
• Friedman HI, DeVenuto F, Zuck TF, et al. Histological and ultrastructural effects of stroma-free hemoglobi n solutions in rat lover, kidney and brain. Surg Forum. 1977;28:3.
   PubMedGoogle Scholar
• Friedman HI, DeVenuto F, Lollini L, et al. Morphologi- cal effects following massive exchange transfusions with a stroma-free hemoglobin solution. I. Liver. Lab Invest. 1978;39:167–177.
   PubMed Web of Science ®Google Scholar
• Friedman HI, DeVenuto F, Lollini L, et al. Morphological effects following massive exchange transfusions with a stroma-free hemoglobin solution. II. Kidney. Lab Invest. 1979;40:655–667.
   PubMed Web of Science ®Google Scholar
• Schuschereba ST, Friedman HI, DeVenuto BE. The mor- phologic effects on the retina of mass exchange transfu-sions with stroma-free hemoglobin solution. Lab Invest. 1983;48:339–352.
   Google Scholar
• Hanks GE, Cassell M, Ray RN, et al. Further modif- cation of the benzidine method for measurement of hemoglobi n in plasma. J Lab Clin Med. 1960;56:486.
   PubMedGoogle Scholar
• Muller-Eberhard U. Hemopexin. N Engl J Med. 1970; 283:1090.
   Google Scholar
• Hershko C. The fate of circulating hemoglobin. Br J Heamatol. 1975;29:199.
   PubMed Web of Science ®Google Scholar
• Bunn HF, Jandl JH. Exchange of heme among hemoglobins and between hemoglobins and albumin. J Biol Chem. 1968;243:465.
   PubMed Web of Science ®Google Scholar
• Bunn HF, Jandl JH. The renal handling of hemoglobin-II, Catabolism. J Exp Med. 1969;129:925.
   PubMed Web of Science ®Google Scholar
• DeVenuto F, Friedman HI, Mellick PW. Massive transfu- sions with crystalline hemoglobin solution and subse-quent replacement of hemoglobi n and blood volume. Surg Gynecol Obstet. 1980;151:361.
   PubMedGoogle Scholar
• Greenberg AG, Hayashi R, Siefert I, Reese H, Peskin GW. Intravascular persistance and oxygen delivery of pyri-doxylated, stroma-free hemoglobi n during gradations of hypotension. Surgery. 1979;86:13.
   PubMedGoogle Scholar
• Greenberg AG, Schooley M, Peskin GW. Improved re-tention of stroma-free hemoglobin by chemical modif-cation. J Trauma. 1977;17:501.
   Google Scholar
• Messmer K, Jesch F, Schaff J, Schoenberg M, Pielsticker K, Bonhard K. Oxygen supply by stroma-free hemoglobin. Proc Clin Biol Res. 1978;19:175.
   PubMedGoogle Scholar
• Sehgal LR, Rosen AL, Gould SA, Sehgal H, Dalton L, Mayoral J. Moss GS. In vitro and in vivo characteristics of polymerized-pyridoxylated hemoglobin solution. Fed Proc. 1980;39:718.
   Google Scholar
• Sehgal LR, Rosen AL, Noud G, Seghal HL, Gould SA, DeWoskin R, Rice CL, Moss GS. Large-volume prepara-tion of pyridoxylated hemoglobi n with high P50. J Surg Res. 1981;30:14.
   PubMed Web of Science ®Google Scholar
• DeVenuto F, Zegna A. Preparation and evaluation of pyridoxylated-polymerized hemoglobin. J Surg Res. 1983;34:205–212.
   PubMed Web of Science ®Google Scholar
• McGarrity MJ, Er SS, Hsia JC. Hemoglobin-base d blood substitutes: Characterization of fve pyridoxyl 5’-phos-phate derivatives of hemoglobin. J Chromatol. 1987; 419:37–50.
   PubMedGoogle Scholar
• Gould S, Rosen A, Sehgal L, et al. The effect of al-tered hemoglobin-oxygen affnity on oxygen transport by hemoglobin solution. J Surg Res. 1980;28:246–251.
   PubMedGoogle Scholar
• Gould SA, Sehgal LR, Rosen AL, Sehgal HL, Levine HD, Rice CL, Moss GS. Hemoglobin solution: Is a normal [Hb] or P50 more important? J Surg Res. 1982;33:189–193.
   Google Scholar
• Fronticelli D, Bucci E, Orth C. Solvent regulation of oxygen affnity in hemoglobin. J Biol Chem. 1984;259:10841–10844.
   PubMed Web of Science ®Google Scholar
• Moss GS, Gould SA, Sehgal LR, Sehgal HL, Rosen AL. Hemoglobi n solution-From tetramer to polymer. Clini-cal review. Surgery. 1984;95:249–255.
   PubMedGoogle Scholar
• Sehgal LR, Rosen AL, Gould SA, Sehgal HL, Moss GS. Preparation and in vitro characteristics of polymerized pyridoxylated hemoglobin. Transfusion. 1983;23:158–162.
   PubMed Web of Science ®Google Scholar
• Sehgal LR, Rosen AL, Gould SA, Seghal HL, Moss GS. An appraisal of polymerized pyridoxylated hemoglobin as an acellular oxygen carrier. In: Bolin RB, Geyer RP, Nemo GJ, eds. Advances in Blood Substitute Research. New York: Alan R. Liss; 1983:19–28.
   Google Scholar
• Sehgal LR, Gould SA, Rosen AL, Sehgal HL, Moss GS. Polymerized pyridoxylated hemoglobin: A red cell sub-stitute with normal oxygen capacity. Surgery. 1984; 95:433–438.
   PubMed Web of Science ®Google Scholar
• Gould SA, Rosen AL, Sehgal LR, Sehgal HL, Moss GS. Polymerized pyridoxylated hemoglobin: Effcacy as an O2 carrier. J Trauma. 1986;26:903–908.
   PubMedGoogle Scholar
• Friedman HI, DeVenuto F, Nemeth TJ. In vivo evalua-tion of pyridoxylated-polymerized hemoglobin solution. Surg Gynecol Obstet. 1984;159:429–435.
   PubMedGoogle Scholar
• Hauser CJ, Kaufman C, Frantz R, Shippy C, Schwartz S, Shoemaker WC. Use of crystalline hemoglobin as re-placement of RBC mass. Arch Surg. 1982;117:782–786.
   PubMedGoogle Scholar
• Vogel WM, Dennis RC, Cassidy G, et al. Coronary vaso- constrictor effect of stroma-free hemoglobi n solutions. Am J Physiol. 1986;251:H413–H420.
   PubMed Web of Science ®Google Scholar
• Vogel WM, Hsia JC, Briggs LL, Er SS, Cassidy G, Apstein CS, Valeri CR. Reduced coronary vasoconstrictor activity of hemoglobin solutions purifed by ATP-agrose affnity chromatography. Life Sci. 1987;41:89–93.
   PubMed Web of Science ®Google Scholar
• Feola M, Simoni J, Canizaro PC, Tran R, Raschbaum G, Behal FJ. Toxicity of polymerized hemoglobin solutions. Surg Gynecol Obstet. 1988;166:211–222.
   PubMedGoogle Scholar
• Hoyt DB, Greenburg AG, Peskin GW, Forbes S, Reese H. Resuscitation with pyridoxylated stroma free hemoglobin: Tolerance to sepsis. J Trauma. 1981;21:938–942.
   PubMedGoogle Scholar
• Hodges GR, Worley SE, Kemner JM, Reed JS. Effect of exchange transfusion with an oxygen-carrying resuscita-tion fuid on the effcacy of penicillin therapy of pneumo-coccal infection in rats. Antimicrob Agents Chemother. 1984;26:903–908.
   PubMed Web of Science ®Google Scholar
• Hertzman CM, Keipert PE, Chang TMS. Serum antibody titers in rats receiving repeated small subcutaneous injec-tions of hemoglobin or polyhemoglobin: A preliminary report. Int J Artiic Organs. 1986;9:179–182.
   PubMed Web of Science ®Google Scholar
• DeVenuto F, Zegna AI, Busse KR. Lypholization of crys-talline hemoglobin solution and exchange transfusions with lypholized, reconstituted hemoglobin. Surg Gy-necol Obstet. 1979;148:69–75.
   PubMedGoogle Scholar
• Djordjevich I, Miller IF. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp Hematol. 1980;8:584–592.
   PubMed Web of Science ®Google Scholar
• Ndong-Nkoum e M, Labrude P, Vigneron C. La mi-croencapsulation de l’he´ moglobine. I. Etude critique des me´ thodes existantes et proposition d’un protocole opti-mise´. Ann Pharm Fr. 1981;39:133–140.
   Google Scholar
• Ndong-Nkoum e M, Labrude P, Humber JC, Teissere B, Vigneron C. La microencapsulation de l’he´ moglobine. II. Etude morphologique et mise en e´ vidence de la perme-abilite´ a` l’oxygene de microcapsules aparoi de polyamide modife´. Ann Pharm Fr. 1981;39:247–253.
   Google Scholar
• Guillochon D, Escalade L, Remy MH, Thomas D. Stud-ies on haemoglobin immobilized by crosslinking with glutaraldehyde, cross-linked soluble polymers and artif-cial membranes. Biochem Biophys Acta. 1981;670:332–340.
   PubMedGoogle Scholar
• Gaber GP, Farmer MC. Encapsulation of hemoglobin in phospholipid vesicles: Preparation and properties of a red cell surrogate. In: The Red Cell: Sixth Ann Arbor Con-ference. New York: Alan R. Liss; 1984:179–190.
   Google Scholar
• Farmer MC, Garber GP. Liposome encapsulated hemo-globin as an artifcial oxygen-carrying system. Methods Enzymol. 1987;149:184–200.
   PubMed Web of Science ®Google Scholar
• Farmer MC, Rudolph AS, Vandegriff KD, et al. Liposome-encapsulated hemoglobin: Oxygen binding properties and respiratory function. Int J Biomater Artif Cells Artif Organs. 1988;16:2979–2990.
   Google Scholar
• Rabinovici R, Rudolph AS, Feuerstein G. Characteriza- tion of hemodynamic, hematologic, and biochemical responses to administration of liposome encapsulated hemoglobi n in the conscious freely moving rat. Circ Shock. 1989;29:115–132.
   PubMedGoogle Scholar
• Rabinovici R, Rudolph AS, Feuerstein G. Improved bi-ological properties of synthetic distearoyl phosphati- dylcholine-based liposome in the conscious rat. Circ Shock. 1990;30:207–219.
   PubMedGoogle Scholar
• Rabinovici R, Rudolph AS, Yue TL, et al. Biologi- cal responses to lip0osome encapsulated hemoglobin (LEH) are improved by a PAF antagonist. Circ Schock. 1990;31:431–445.
   PubMedGoogle Scholar
• Rabinovici R, Rudolph AS, Ligler F, et al. Biological re-sponses to exchange transfusion with liposome encap-sulated hemoglobi n (LEH). Circ Schock. 1992;37:124–133.
   PubMedGoogle Scholar
• Rabinovici R, Rudolph AS, Feuerstein G. A new salutary resuscitative fuid: Lipsome encapsulated hemoglobin (LEH)-hypertonic saline solution. J Trauma. 1993;35:121–127.
   PubMedGoogle Scholar
• Rudolph AS, Cliff RO. Dry storage of liposome encap-sulated hemoglobin: A blood substitute. Cryobiology. 1990;27:585–593.
   PubMedGoogle Scholar
• Cliff RO, Ligler F, Goins B, et al. Liposome encapsulated hemoglobin: Long-term storage stability and in vivo characterization. Biomater Artif Cells Immob Biotechnol. 1992;20:619–626.
   PubMed Web of Science ®Google Scholar
• Rabinovici R, Rudolph AS, Vernicj J, et al. Lypholyzed liposome encapsulated hemoglobin: Evaluation of he-modynamic, biochemical, and hematologi c responses. Crit Care Med. 1994;22:480–485.
   PubMed Web of Science ®Google Scholar
• Rudoph AS, Klipper RW, Goins B, et al. In vivo biodistri- bution of a radiolabeled blood substitute.99m-Tc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. Proc Natl Acad Sci USA. 1991;88:10976–10980.
   Google Scholar
• Rabinovici R, Sung C-P, Rudolph As, et al. Effect of lipo-some encapsulated hemoglobi n (LEH) on adhesiveness of human umbilical vein endothelial cells for monocyte U937 cells. Pharm Commun. 1992;1:195–202.
   Google Scholar
• Langdale LA, Maier RV, Wilson L, et al. Liposome en-caspsulated hemoglobi n inhibits tumor necrosis fac-tor from rabbit alveolar macrophages by a posttran-scriptional mechanism. J Leukocyte Biol. 1992;52:679–686.
   PubMed Web of Science ®Google Scholar
• Rudolph AS, Cliff RO, Spargo BJ, et al. Transient changes in the mononuclear phagocytic system following admin-istration of the blood substitute, liposome encapsulated hemoglobin. Biomaterials. 1994;15:796–804.
   PubMed Web of Science ®Google Scholar
• Chatterjee R, Welty EV, Walder RY, Pruitt SL, Rogers PH, Arnone A, Walder JA. Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (Lysine 99 alpha 1-Lysine 99 alpha 2). J Biol Chem. 1986;261:9929–9937.
   PubMed Web of Science ®Google Scholar
• Snyder SR, Welty EV, Walder RY, William LA, Walder JA. HbXL99a: A hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substi-tute. Proc Natl Acad Sci USA. 1987;84:7280–7284.
   PubMed Web of Science ®Google Scholar
• Urbaitis BK, Razynska A, Cortexa Q, Fronticelli C, Bucci E. Intravascular retention and renal handling of purifed natural and intramolecularly cross-linked hemoglobins. J Lab Clin Med. 1990;117:115–121.
   Web of Science ®Google Scholar
• Nelson D, Hai T, Srnak A, Ebeling A, Kunis G, Catarello J, Burhop K. Synthesis and properties of polymerized, diaspirin cross-linked hemoglobins. Biomater Artif Cells Immob Biotechnol. 1992;20:253–258.
   PubMed Web of Science ®Google Scholar
• Vandergriff KD, Medina F, Marini MA, Winslow RM. Equilibrium oxygen binding to aa-cross-linked human hemoglobin. J Biol Chem. 1989;264:17824–17833.
   PubMedGoogle Scholar
• Hess JR, Fadare SO, Tolentino LS, et al. The intravas-cular persistence of cross-linked human hemoglobin. In: The Red Cell: Seventh Ann Arbor Conference. New York: Alan R. Liss, 1989:351–360.
   Google Scholar
• Przybelski RJ, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, Colburn WA. Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobi n solution. Crit Care Med. 1996;24:1993–2000.
   PubMed Web of Science ®Google Scholar
• Nelson D, Azari M, Brown R, Burhop K, et al. Prepa- ration and characterization of diaspirin cross-linked hemoglobi n solutions for preclinical studies. Biomater Artif Cells Immob Biotechnol. 1992;20:423–427.
   PubMed Web of Science ®Google Scholar
• Przybelski RJ, Malcolm DS, Burris DG, Winslow RM. Cross-linked hemoglobin solution as a resuscitative fuid after hemorrhage in the rat. J Lab Clin Med. 1991; 117:143–151.
   PubMed Web of Science ®Google Scholar
• Malcolm DS, Kissinger D, Garrioch M, et al. Diaspirin cross-linked hemoglobin solution as a resuscitation fuid following severe hemorrhage. Biomater Artif. Cells Im-mob Biotechnol. 1992;20:495–497.
   PubMed Web of Science ®Google Scholar
• Schultz SC, Powell CC, Burris DG, et al. The effcacy of diaspirin cross-linked hemoglobi n solution resuscita-tion in a model of uncontrolled hemorrhage. J Trauma. 1994;37:408–412.
   PubMed Web of Science ®Google Scholar
• Cohn SM, Farrell TJ. Diaspirin cross-linked hemoglobi n resuscitation of hemorrhage: Comparison of a blood substitute with hypertonic saline and isotonic saline. J Trauma. 1995;39:210–217.
   PubMed Web of Science ®Google Scholar
• Dunlap E, Farrell L, Nigro C, Estep T, Marchand G, Burhop K. Resuscitation with diaspirin cross-linked hemoglobi n in a pig model of hemorrhage shock. Artif Cells Blood Sub Immob Biotechnol. 1995;23:39–61.
   PubMed Web of Science ®Google Scholar
• Marchand G, Dunlap E, Farrell L, Nigro C. Resusci- tation with increasing doses of diaspirin cross-linked hemoglobi n in swine. Artif Cells Blood Sub Immob Biotechnol. 1996;24:469–487.
   PubMed Web of Science ®Google Scholar
• DeAngeles DA, et al. Resuscitation from hemorrhagi c shock with diaspirin cross-linked hemoglobin, blood, hetastarch. J Trauma. 1997;42:406–412.
   Google Scholar
• Frankel HL, et al. Diaspirin cross-linked hemoglobin is effcacious in gut resuscitation as measured by GI tract optode. J Trauma. 1996;40:231–240.
   PubMedGoogle Scholar
• Powell CC, Schultz SC, Malcolm DS. Diaspirin cross- linked hemoglobin more effective than lactated Ringer’s solution in restoring central venous oxygen saturation after hemorrhagic shock in rats. Artif Cells Blood Sub Immob Biotechnol. 1996;24:197–200.
   PubMed Web of Science ®Google Scholar
• Gulati A, Rebello S. Diaspirin cross-linked hemoglobi n (DCLHB): Involvement of adrenergic mechansims in the pressor effect. Artif Cells Blood Sub Immob Biotechnol. 1994;22:603-612.Gulati A, Rebello S. Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med. 1994;124:125–133.
   PubMed Web of Science ®Google Scholar
• Gulati A, Sharma AC, Singh G. Role of endothelin in the cardiovascular effects of diaspirin cross-linked and stroma-reduced hemoglobin. Crit Care Med. 1996; 24:137–147.
   PubMed Web of Science ®Google Scholar
• Gulati A, Singh G, Rebello S, Sharma AC. Effect of diaspirin cross-linked stroma-reduced hemoglobin on mean arterial pressure and endothelin-1 concentration in rats. Life Sci. 1995;56:1433–1442.
   PubMed Web of Science ®Google Scholar
• Sharma AC, Rebello S, Gulati BS, Gulati A. Regional cir- culatory and systemic hemodynamic effects of diaspirin cross-linked hemoglobin in the rat. Artif Cells Blood Sub Immob Biotechnol. 1994;22:593–602.
   PubMed Web of Science ®Google Scholar
• Gulati A, Sharma AC, Burhop K, Burhop S. Effect of stroma free hemoglobin and diaspirin cross linked hemoglobi n on the regional circulation and systemic hemodynamics. Life Sci. 1994;55:827–837.
   PubMed Web of Science ®Google Scholar
• Hess JR, MacDonald VW, Brinkley WW. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol. 1993;74:1769–1778.
   PubMed Web of Science ®Google Scholar
• Sharma AC, Singh G, Gulati A. Role of nitric oxide mech- anism in the cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am Physiol. 1995;269:H1379–H1388.
   PubMedGoogle Scholar
• Freas W, Llave R, Jing M, Hart J, Maquillan P, Maldoon S. Contractile effects of diaspirin cross-linked hemoglobi n on isolated porcine blood vessels. J Lab Med. 1995;125:762–767.
   PubMedGoogle Scholar
• Katsuyama SS, Cole DJ, Drummond JC, Bradley K. Nitric oxide mediates the hypertensive response to modifed hemoglobi n solution (DCLHbTM) in rats. Artif Cells Blood Sub Immob Biotechnol. 1994;22:1–7.
   PubMed Web of Science ®Google Scholar
• Abassi Z, Kotob S, Pieruzzi F, et al. Effects of polymeriza- tion on the hypertensive action of diaspirin cross-linked hemoglobi n in rats. J Lab Clin Med. 1997;129:603–610.
   PubMedGoogle Scholar
• Reah G, Bodenham AR, Mallick A, Daily EK, Przybelski RJ. Initial evaluation of diaspirin cross-linked hemoglobi n (DCLHb) as a vasopressor in critically ill patients. Crit Care Med. 1997;25:1480–1488.
   PubMed Web of Science ®Google Scholar
• Estep TN, Gonder J, Bornstein I, Aono F. Immunogenicity of diaspirin cross-linked human hemoglobin solutions. Biomater Artif Cells Immob Biotechnol. 1992;20:603–609.
   PubMed Web of Science ®Google Scholar
• Patel MJ, Webb EJ, Shelbour n TE, Mattia-Goldberg C, George AJT, Zhang F, Moore E, Nelson DJ. Absence of immunogenicity of diaspirin cross-linked hemoglobin in humans. Blood. 1998;91:710–718.
   PubMedGoogle Scholar
• Vlahakes GJ, Lee R, Jacobs EE, et al. Hemodynami c ef- fects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg. 1990;100:379–388.
   PubMed Web of Science ®Google Scholar
• Garcia-Gallont R, Herrera-Llerandi R, Lopez Herrera- Llerandi E. Determination of safety on infusing a bovine-derived, ultrapure, polymerized hemoglobin solution into healthy volunteers. Biomater Artif Cells Immob Biotechnol. 1991:19:328.
   Google Scholar
• Hughes GS, Antal EJ, Locker PK, Francom SF, Adams WJ, Jacobs EE. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med. 1996;24:756–765.
   PubMed Web of Science ®Google Scholar
• Ogden JE, Parry ES. The development of hemoglobin as red cell substitutes. Int Anesthes Clin. 1995;33:115–129.
   PubMedGoogle Scholar
• Gould SA, Sehgal LR, Seghal HL, Toyoke E, Moss GS. Clin-ical experience with human polymerized hemoglobin. Transfusion. 1993;33:60S.
   Google Scholar
• Gould SA, Moore EE, Moore FA, Haenel JB, Burch JM, Sehgal H, Sehgal L, DeWoskin R, Moss GS. Clinical utility of human polymerized hemoglobi n as a blood substitute after acute trauma and urgent surgery. J Trauma. 1997;43:325–332.
   PubMed Web of Science ®Google Scholar
• Gould SA, Moore EE, Hoyt DB, Burch JM, Haenel JB, Garcia J, DeWoskin R, Moss GS. The frst randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg. 1998;187:113–122.
   PubMed Web of Science ®Google Scholar
• O’Donnell JK, Martin MJ, Logan JS, Kumar R. Production of heman hemoglobin in transgenic swine: An approach to a blood substitute. Cancer Detect Prev. 1993;17:307–312.
   PubMedGoogle Scholar
• Looker D, Abbott-Brown D, Cozart P, et al. A human recombinant hemoglobi n designed for use as a blood substitute. Nature 1992;356:258.
   PubMed Web of Science ®Google Scholar
• DeVenuto F, Friedman HI, Neville RJ, Peck CC. Appraisal of hemoglobin solution as a blood substitute. Surg Gy-necol Obstet. 1979;149:417–436.
   PubMedGoogle Scholar